Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation
Oral cancer is often diagnosed only at advanced stages due to a lack of reliable disease markers. The purpose of this study was to determine if the epithelial-specific human calmodulin-like protein (CALML3) could be used as marker for the various phases of oral tumor progression. Immunohistochemical...
Main Authors: | Michael D. Brooks, Richard D. Bennett, Amy L. Weaver, Thomas J. Sebo, Steven E. Eckert, Emanuel E. Strehler, Alan B. Carr |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | International Journal of Dentistry |
Online Access: | http://dx.doi.org/10.1155/2013/592843 |
Similar Items
-
Immunolocalization of the tumor-sensitive calmodulin-like protein CALML3 in normal human skin and hyperproliferative skin disorders.
by: Richard D Bennett, et al.
Published: (2013-01-01) -
The EF-Hand Protein CALML6 Suppresses Antiviral Innate Immunity by Impairing IRF3 Dimerization
by: Ziyang Wang, et al.
Published: (2019-01-01) -
Loss of Immunoreactivity for Human Calmodulin-Like Protein is an Early Event in Breast Cancer Development
by: Michael S. Rogers, et al.
Published: (1999-08-01) -
Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers
by: Vatn Morten, et al.
Published: (2008-12-01) -
A comparative study on the mast cells count in oral squamous cell carcinoma and normal oral mucosa
by: Mahsa Dastpak, et al.
Published: (2015-03-01)